Wulff, Hansen & Co’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$314K Buy
3,420
+110
+3% +$9.62K 0.24% 87
2026
Q1
$282K Hold
3,310
– – 0.29% 86
2025
Q4
$262K Hold
3,310
– – 0.22% 91
2025
Q3
$265K Hold
3,310
– – 0.23% 89
2025
Q2
$301K Hold
3,310
– – 0.26% 89
2025
Q1
$310K Hold
3,310
– – 0.28% 82
2024
Q4
$301K Hold
3,310
– – 0.28% 79
2024
Q3
$344K Hold
3,310
– – 0.31% 73
2024
Q2
$321K Hold
3,310
– – 0.32% 71
2024
Q1
$298K Sell
3,310
-120
-3% -$10.2K 0.3% 71
2023
Q4
$273K Sell
3,430
-315
-8% -$23.7K 0.3% 73
2023
Q3
$266K Hold
3,745
– – 0.31% 72
2023
Q2
$289K Hold
3,745
– – 0.32% 68
2023
Q1
$281K Hold
3,745
– – 0.32% 67
2022
Q4
$295K Hold
3,745
– – 0.36% 63
2022
Q3
$263K Hold
3,745
– – 0.33% 71
2022
Q2
$300K Hold
3,745
– – 0.34% 69
2022
Q1
$284K Hold
3,745
– – 0.27% 77
2021
Q4
$320K Buy
+3,745
New +$292K 0.28% 72

Other funds holding CL

Wulff, Hansen & Co's CL Position: Q2 2026 in Review

Wulff, Hansen & Co increased its Colgate-Palmolive (CL) stake by 3.3% in Q2 2026, buying an estimated $9.62K and bringing the position to 3,420 shares worth $314K. The position accounts for 0.24% of the portfolio, ranked #87.

Wulff, Hansen & Co first reported a position in CL in Q4 2021 and has held it in 19 quarters since. The position peaked at $344K in Q3 2024. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Wulff, Hansen & Co held 3,420 shares of Colgate-Palmolive worth $314K as of Q2 2026.
  • Wulff, Hansen & Co bought 110 Colgate-Palmolive shares in Q2 2026, an estimated $9.62K.
  • Colgate-Palmolive made up 0.24% of Wulff, Hansen & Co's portfolio in Q2 2026, its #87 holding.
  • Wulff, Hansen & Co first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 19 quarters since.
  • Wulff, Hansen & Co's Colgate-Palmolive position peaked at $344K in Q3 2024.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Wulff, Hansen & Co's 13F filing for Q2 2026, filed 5 Aug 2026.